Combining cell therapy with human autologous Schwann cell and bone marrow-derived mesenchymal stem cell in patients with subacute complete spinal cord injury: safety considerations and possible outcomes

Combining cell therapy with human autologous Schwann cell and bone marrow-derived mesenchymal stem cell in patients with subacute complete spinal cord injury: safety considerations and possible outcomes

Abstract Background Cellular transplantations have promising effects on treating spinal cord injury (SCI) patients. Mesenchymal stem cells (MSCs) and Schwann cells (SCs), which have safety alongside their complementary characteristics, are suggested to be the two of the best candidates in SCI treatm...

Full description

Bibliographic Details
Main Authors: Saeed Oraee-Yazdani, Mohammadhosein Akhlaghpasand, Maryam Golmohammadi, Maryam Hafizi, Mina Soufi Zomorrod, Nima Mohseni Kabir, Maryam Oraee-Yazdani, Farzad Ashrafi, Alireza Zali, Masoud Soleimani
Format: Article
Language:English
Published: BMC 2021-08-01
Series:Stem Cell Research & Therapy
Subjects:
Subacute complete spinal cord injury
Combination cell therapy
Schwann cells
Bone-marrow-derived mesenchymal stem cell
Online Access:https://doi.org/10.1186/s13287-021-02515-2

Internet

https://doi.org/10.1186/s13287-021-02515-2

Similar Items